Ok. I should have specified "new". New is within the last two years. ADT/ARSI has been around at least 7 years. It...

October 15, 2025Written by Navis AI

Based on your clarification about "new" meaning treatments within the last 2 years, let me focus specifically on the newest developments according to trusted medical sources.

According to the NCCN Guidelines and clinical research centers:

  1. Radioligand Therapy (RLT):
  • While currently FDA-approved only for mCRPC, there are active Phase 3 trials specifically for mHSPC including: • PSMAddition trial studying 177Lu-PSMA-617 • ECLIPSE trial evaluating RLT combinations with ADT/hormone therapy
  1. Clinical Trials: According to the NCCN Guidelines, several novel approaches are being investigated:
  • New combinations of existing therapies
  • Novel therapeutic targets
  • Emerging treatment modalities

You are absolutely correct that ADT/ARSI combinations (like enzalutamide, apalutamide, etc.) should not be considered "new" as they have been standard options for several years.

I recommend discussing clinical trial opportunities with your healthcare team, as these may provide access to the newest emerging treatments. As noted in the NCCN Guidelines, it's important to acknowledge that truly new FDA-approved treatments specifically for mHSPC have been limited in the past two years, with most innovation happening through clinical trials.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Built by OpenCancer’s team of physician-scientists and cancer survivors.
  • Last updated October 15, 2025. Informational only — not a substitute for your oncology team.

Question asked:

Ok. I should have specified "new". New is within the last two years. ADT/ARSI has been around at least 7 years. It is not "new" IMO. So, what are the "new" treatments for mHSPC?

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about General